NCT00001563View on ClinicalTrials.gov

EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients With AIDS-Associated Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

January 8, 1997

Primary Completion Date

May 5, 2005

Study Completion Date

May 5, 2005

Conditions
AIDS Related LymphomaAIDS-Associated Lymphoma
Interventions
BIOLOGICAL

Filgrastim

Filgrastim after EPOCH-R from Day 6 for 10 days every cycle.

BIOLOGICAL

Rituximab

EPOCH-R every 3 weeks for up to 6 cycle

DRUG

EPOCH

EPOCH-R every 3 weeks for up to 6 cycle

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00001563 - EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients With AIDS-Associated Lymphoma | Biotech Hunter | Biotech Hunter